Congress responds to the IOM drug safety report--in full.

Congress responds to the IOM drug safety report--in full.

Item
http://www.wikidata.org/entity/Q50866392
National trends in treatment of type 2 diabetes mellitus, 1994-2007Clinical trial design and selected drug safety issues for antibiotics used to treat community-acquired pneumoniaInternational society for disease surveillance conference 2011: building the future of public health surveillancePotential and pitfalls of using large administrative claims data to study the safety of osteoporosis therapies.Performance of a semi-automated approach for risk estimation using a common data model for longitudinal healthcare databases.The Food and Drug Administration's Drug Safety Oversight Board: an evolving paradigm for clinical input on drug safety topics.Understanding risk evaluation and mitigation strategies in organ transplantation.A guide to understanding and implementing risk evaluation and mitigation strategies in organ transplantation.
P2860

Congress responds to the IOM drug safety report--in full.

Item
http://www.wikidata.org/entity/Q50866392
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Congress responds to the IOM drug safety report--in full.
@en
Congress responds to the IOM drug safety report--in full.
@nl
type
label
Congress responds to the IOM drug safety report--in full.
@en
Congress responds to the IOM drug safety report--in full.
@nl
prefLabel
Congress responds to the IOM drug safety report--in full.
@en
Congress responds to the IOM drug safety report--in full.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Congress responds to the IOM drug safety report--in full.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698